Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pain
- Vol. 6 (1), 21-28
- https://doi.org/10.1016/j.jpain.2004.09.005
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Efficacy and Safety of Oral Immediate-Release Oxymorphone for Postsurgical PainAnesthesia & Analgesia, 2004
- Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled studyCurrent Medical Research and Opinion, 2004
- Use of Lidocaine Patch 5% for Chronic Low Back Pain: A Report of Four CasesPain Medicine, 2002
- Evidence For and Against the Use of Opioid Analgesics for Chronic Nonmalignant Low Back Pain: A Review: Table 1Pain Medicine, 2002
- Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to-Severe Osteoarthritis Pain: Results from a Randomized, Placebo-Controlled, Double-Blind Trial and an Open-Label Extension TrialJournal of Pain and Symptom Management, 2002
- Opioid Therapy for Chronic Noncancer Back PainSpine, 1998
- The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediatedPain, 1997
- Randomised trial of oral morphine for chronic non-cancer painThe Lancet, 1996
- Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trialPain, 1995
- A Comparison of Morphine, Meperidine, and Oxymorphone as Utilized in Patient-controlled Analgesia Following Cesarean DeliveryAnesthesiology, 1989